Navigation Links
Nutrition 21 to Report Second Quarter Fiscal 2008 Financial Results Monday, February 11, 2008
Date:2/5/2008

PURCHASE, N.Y., Feb. 5 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. (Nasdaq: NXXI), a growing developer and marketer of nutritional supplements under the Chromax(R), Diabetes Essentials(TM) and Iceland Health(R) brands that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory, and address chronic joint pain, will report financial results for the second quarter of fiscal year 2008, ended December 31, 2007 on Monday, February 11, 2008, after market close. The Company has scheduled a conference call to discuss the results of the quarter on Tuesday, February 12, 2008, at 8:30AM ET.

Participants can dial (866) 562-9910 or (706) 679-5064 to access the conference call, or can listen via a live Internet web cast, which can be found at http://www.nutrition21.com. A replay of the call is available by visiting http://www.nutrition21.com for the next 30 days or by calling (800) 642-1687 or (706) 645-9291, access code 32156566, through February 14, 2008.

About Nutrition 21

Nutrition 21, Inc. (NASDAQ: NXXI), headquartered in Purchase, NY, is a nutritional bioscience company and the maker of chromium picolinate-based and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. Nutrition 21 holds more than 30 patents for nutrition products and uses. Nutrition 21's portfolio of health and wellness brands include: Chromax(R), Core4Life(TM) Advanced Memory Formula(TM), Diabetes Essentials(TM), Iceland Health(R) Maximum Strength Omega-3 and Iceland Health(R) Joint Relief. The company also manufactures private label supplements and ingredients for third parties. Nutrition 21 distributes its products nationally through more than 29,000 major food, drug and super center retailers as well as internationally. More information is available at http://www.nutrition21.com/.

Contacts:

Nutrition 21, Inc. Lytham Partners, LLC

Maryrose Lombardo Joe Diaz, Robert Blum, Joe Dorame

914-701-4525 (602) 889-9700


'/>"/>
SOURCE Nutrition 21, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Max Nutrition, Inc. Completes Share Exchange with American Spring Pharmaceutical, Inc.
2. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
3. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
4. Salugens Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis
5. Salugen Expands U.S. Distribution and Announces a Partnership with DNA Dimensions to Bring DNA Customized Nutritional Solutions to Metro Detroit Area
6. Pilot Therapeutics Announces New Executive Team with Extensive Experience Creating New Health and Nutrition Businesses
7. CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public
8. Salugen to Present at Nutrition Capital Networks First In-Person Investor Meeting
9. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
10. Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management
11. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... Norwood, MA (PRWEB) , ... February 28, 2017 ... ... successful clinical trials, yet requires extensive coordination and expertise. Colpitts Clinical Trial ... is celebrating 15 years of meeting this unique need within the biotechnology and ...
(Date:2/28/2017)... ... February 28, 2017 , ... GigaGen Inc ., a ... repertoires, today announced a strategic partnership with Trianni, Inc. , a biotechnology ... antibodies. The partnership will use GigaGen technology to discover immuno-oncology antibody therapeutics through ...
(Date:2/28/2017)... 28, 2017 Sangamo Therapeutics, Inc. (NASDAQ: ... reported its fourth quarter and full year 2016 ... this year we rebranded our company as Sangamo ... genomic therapies using our industry leading platform technologies ... cell therapy," said Sandy Macrae , CEO ...
(Date:2/27/2017)... VANCOUVER , Feb. 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, ... to their expiry on Friday, February 24, 2017 a total ... a price of $0.13 per common share. Proceeds from the ... were issued from InMed,s Treasury.   ... "We are grateful for this expression ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
(Date:2/8/2017)... (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2016. Revenue ... to $6.9 million in the same quarter last year. Operating ... compared to $2.6 million in the fourth quarter of 2015. ... million, or $0.02 per diluted share, which compares to $1.8 ...
Breaking Biology News(10 mins):